Dentsply Sirona (XRAY) Total Non-Current Liabilities (2009 - 2026)
Dentsply Sirona's (XRAY) quarterly Total Non-Current Liabilities came in at $3.4 billion in Q1 2026, down 5.99% YoY from $3.6 billion in Q1 2025, and down 4.32% on a QoQ basis from $3.5 billion in Q4 2025.
Dentsply Sirona (XRAY) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Dentsply Sirona (XRAY) has 18 years of Total Non-Current Liabilities data on file, last reported at $3.4 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 5.99% year-over-year to $3.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 billion (down 5.99% YoY) and the FY2025 annual result came in at $3.5 billion, up 4.42% from the prior year.
- Total Non-Current Liabilities retreated to $3.4 billion in Q1 2026, from $3.5 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $3.8 billion in Q4 2022 to a low of $3.4 billion in Q2 2024.
- A 5-year average of $3.5 billion and a median of $3.6 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities declined 9.42% — and 2024, when it advanced 6.76%.
- Tracing XRAY's Total Non-Current Liabilities over 5 years: stood at $3.8 billion in 2022, then declined by 6.61% to $3.6 billion in 2023, then dropped by 5.01% to $3.4 billion in 2024, then increased by 4.42% to $3.5 billion in 2025, then fell by 4.32% to $3.4 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $3.4 billion (Q1 2026), $3.5 billion (Q4 2025), and $3.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Dentsply Sirona | 2.16 Bn | 1.92 Bn | 493.00 Mn | 3.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.35 Bn |
| Mar 31, 2026 | 3.39 Bn |
| Dec 31, 2025 | 3.55 Bn |
| Sep 30, 2025 | 3.60 Bn |
| Jun 30, 2025 | 3.59 Bn |
| Mar 31, 2025 | 3.61 Bn |
| Dec 31, 2024 | 3.40 Bn |
| Sep 30, 2024 | 3.63 Bn |
| Jun 30, 2024 | 3.37 Bn |
| Mar 31, 2024 | 3.41 Bn |
| Dec 31, 2023 | 3.57 Bn |
| Sep 30, 2023 | 3.40 Bn |
| Jun 30, 2023 | 3.52 Bn |
| Mar 31, 2023 | 3.63 Bn |
| Dec 31, 2022 | 3.83 Bn |
| Sep 30, 2022 | 3.43 Bn |
| Jun 30, 2022 | 3.62 Bn |
| Mar 31, 2022 | 3.79 Bn |
| Dec 31, 2021 | 4.23 Bn |
| Sep 30, 2021 | 3.66 Bn |